CITIGROUP INC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 198 filers reported holding MYRIAD GENETICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$1,953,351
-27.3%
121,780
+5.0%
0.00%
-50.0%
Q2 2023$2,688,440
-33.9%
115,981
-33.8%
0.00%
-33.3%
Q1 2023$4,066,946
+97.1%
175,073
+23.1%
0.00%
+50.0%
Q4 2022$2,063,075
-45.2%
142,183
-28.0%
0.00%
-33.3%
Q3 2022$3,768,000
+39.0%
197,503
+32.4%
0.00%
+50.0%
Q2 2022$2,711,000
+0.8%
149,221
+39.9%
0.00%0.0%
Q1 2022$2,689,000
-54.6%
106,684
-50.3%
0.00%
-33.3%
Q4 2021$5,925,000
+38.3%
214,656
+61.8%
0.00%0.0%
Q3 2021$4,284,000
-31.0%
132,661
-34.7%
0.00%
-25.0%
Q2 2021$6,209,000
+44.5%
203,031
+43.9%
0.00%
+33.3%
Q1 2021$4,296,000
+97.5%
141,057
+28.2%
0.00%
+50.0%
Q4 2020$2,175,000
+61.5%
110,042
+6.5%
0.00%
Q3 2020$1,347,000
-52.9%
103,366
-59.0%
0.00%
-100.0%
Q2 2020$2,862,000
-22.3%
252,417
-1.9%
0.00%
-33.3%
Q1 2020$3,683,000
-21.5%
257,311
+49.3%
0.00%0.0%
Q4 2019$4,692,000
-6.1%
172,290
-1.3%
0.00%
-25.0%
Q3 2019$4,999,000
+86.0%
174,618
+80.4%
0.00%
+100.0%
Q2 2019$2,687,000
-15.4%
96,773
+1.2%
0.00%
-33.3%
Q1 2019$3,176,000
-52.5%
95,654
-58.4%
0.00%
-57.1%
Q4 2018$6,688,000
+470.6%
230,049
+802.5%
0.01%
+600.0%
Q3 2018$1,172,000
+71.3%
25,490
+39.1%
0.00%
Q2 2018$684,000
+138.3%
18,320
+88.6%
0.00%
Q1 2018$287,000
-93.1%
9,716
-92.0%
0.00%
-100.0%
Q4 2017$4,155,000
-26.0%
120,979
-22.0%
0.00%
-40.0%
Q3 2017$5,612,000
+16.5%
155,131
-16.8%
0.01%
+25.0%
Q2 2017$4,817,000
+63.2%
186,418
+21.3%
0.00%
+100.0%
Q1 2017$2,951,000
-54.9%
153,711
-60.8%
0.00%
-66.7%
Q4 2016$6,542,000
+1062.0%
392,452
+1334.9%
0.01%
Q3 2016$563,000
+4.1%
27,350
+54.5%
0.00%
-100.0%
Q2 2016$541,000
-78.1%
17,705
-73.2%
0.00%
-66.7%
Q1 2016$2,473,000
+256.3%
66,105
+311.5%
0.00%
+200.0%
Q4 2015$694,000
-37.9%
16,065
-46.1%
0.00%0.0%
Q3 2015$1,118,000
+66.9%
29,830
+51.2%
0.00%0.0%
Q2 2015$670,000
+14.9%
19,725
+19.8%
0.00%0.0%
Q1 2015$583,000
-43.3%
16,465
-45.6%
0.00%0.0%
Q4 2014$1,029,000
+82.1%
30,265
+106.5%
0.00%
Q3 2014$565,000
+60.5%
14,656
+62.0%
0.00%
Q2 2014$352,000
+10.0%
9,045
-3.4%
0.00%
Q1 2014$320,000
+91.6%
9,367
+18.1%
0.00%
Q4 2013$167,000
-60.4%
7,932
-55.9%
0.00%
Q3 2013$422,000
+711.5%
17,982
+836.1%
0.00%
Q2 2013$52,0001,9210.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 6,459,139$278,776,0005.53%
Tieton Capital Management, LLC 119,290$5,149,0004.04%
RPg Family Wealth Advisory, LLC 97,202$4,195,238,0003.85%
RK Capital 384,900$16,612,0002.90%
Contrarius Investment Management Ltd 652,288$28,153,0002.65%
S&T BANK/PA 331,885$14,324,0002.22%
Euclidean Technologies Management, LLC 40,917$1,766,0001.90%
AIMZ Investment Advisors, LLC 45,635$1,970,0001.80%
Taylor Frigon Capital Management LLC 34,783$1,486,0001.67%
KILLEN GROUP INC 366,305$15,810,0001.63%
View complete list of MYRIAD GENETICS INC shareholders